Advances in Eye Inflammation Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 335
Special Issue Editor
Interests: cataracts; corneal pathology and treatment; eye traumatology; neuroprotection
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue will gather publications that focus on two key processes of the inflammation of the eye tissues. By definition, inflammation is a complex biological response of tissue to harmful stimuli. The inflammatory response activates cellular and biochemical cascades of mechanisms, involving molecular mediators, immune cells and blood vessels, in order to protect the organism by eliminating the cause and repairing the tissue. Inflammation can be divided according to duration as acute or chronic.
Inflammation is implicated in the pathogenesis of numerous ophthalmological diseases involving all eye structures. Studies reveal elements of the inflammatory response in disorders which were considered as degenerative. Recently, anti-inflammatory treatment has been developed, and novel therapeutic options are finding new indications.
We warmly invite authors and investigators to submit original articles and reviews focused on the latest achievements in considering the role of inflammation and the implementation of anti-inflammatory treatment within all eye structures.
Dr. Tomasz Chorągiewicz
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammation
- anti-inflammatory
- inflammatory response
- eye pathology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
